These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34955523)

  • 21. Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
    Ousmane S; Kobayashi M; Seidou I; Issaka B; Sharpley S; Farrar JL; Whitney CG; Ouattara M
    Vaccine; 2020 May; 38(23):3922-3929. PubMed ID: 32327220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.
    Ampofo K; Pavia AT; Chris S; Hersh AL; Bender JM; Blaschke AJ; Weng HY; Korgenski KE; Daly J; Mason EO; Byington CL
    Pediatr Infect Dis J; 2012 Mar; 31(3):228-34. PubMed ID: 22330164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-based sentinel surveillance for
    Rajkumar P; Bharathy S; Girish Kumar CP; Veeraraghavan B; Verghese V; Gupta N; Kangusamy B; Ravi M; Jayaraman Y; ;
    BMJ Open; 2020 Apr; 10(4):e034663. PubMed ID: 32273315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the line probe assay for the rapid detection of bacterial meningitis pathogens in cerebrospinal fluid samples from children.
    Soysal A; Toprak DG; Türkoğlu S; Bakir M
    BMC Microbiol; 2017 Jan; 17(1):14. PubMed ID: 28077083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
    Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangare L; Yaméogo I; Sawadogo G; Ouédraogo AS; Hema-Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Sanou S; Ba AK; Novak RT; Van Beneden C;
    PLoS One; 2016; 11(11):e0166384. PubMed ID: 27832151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
    Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014.
    Oligbu G; Collins S; Sheppard CL; Fry NK; Slack M; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Jul; 65(2):308-314. PubMed ID: 28605414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
    Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype Distribution and Antimicrobial Resistance of
    Kim GR; Kim EY; Kim SH; Lee HK; Lee J; Shin JH; Kim YR; Song SA; Jeong J; Uh Y; Kim YK; Yong D; Kim HS; Kim S; Kim YA; Shin KS; Jeong SH; Ryoo N; Shin JH
    Ann Lab Med; 2023 Jan; 43(1):45-54. PubMed ID: 36045056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
    Tagbo BN; Bancroft RE; Fajolu I; Abdulkadir MB; Bashir MF; Okunola OP; Isiaka AH; Lawal NM; Edelu BO; Onyejiaka N; Ihuoma CJ; Ndu F; Ozumba UC; Udeinya F; Ogunsola F; Saka AO; Fadeyi A; Aderibigbe SA; Abdulraheem J; Yusuf AG; Sylvanus Ndow P; Ogbogu P; Kanu C; Emina V; Makinwa OJ; Gehre F; Yusuf K; Braka F; Mwenda JM; Ticha JM; Nwodo D; Worwui A; Biey JN; Kwambana-Adams BA; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S81-S88. PubMed ID: 31505626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; Del Castillo F; Hernández-Sampelayo T; Otheo E; Balboa F; Ríos E; Méndez C;
    Clin Vaccine Immunol; 2011 Jan; 18(1):89-94. PubMed ID: 21047996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
    Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
    BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
    Nigrovic LE; Kuppermann N; Malley R;
    Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study.
    Shrestha S; Gurung M; Amatya P; Bijukchhe S; Bose AS; Carter MJ; Gautam MC; Gurung S; Hinds J; Kandasamy R; Kelly S; Khadka B; Maskey P; Mujadidi YF; O'Reilly PJ; Pokhrel B; Pradhan R; Shah GP; Shrestha S; Wahl B; O'Brien KL; Knoll MD; Murdoch DR; Kelly DF; Thorson S; Voysey M; Pollard AJ;
    Lancet Glob Health; 2022 Oct; 10(10):e1494-e1504. PubMed ID: 36113533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.